MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
GRCL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Gracell Biotechnologies (GRCL) Ownership - Who owns Gracell Biotechnologies?

Gracell Biotechnologies Inc is a clinical-stage biopharmaceutical company focused on developing and discovering cell and gene therapies to address and fulfill unmet medical needs in the treatment of cancer... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
218 Sangtian Street
Phone
+86 51262626701
Employees
314
Web
https://www.gracellbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
989.87M
P/E Ratio
N/A
Total Cash
1.71B
Projected Growth
N/A
Total Debt
115.82M
Revenue
N/A
Risk (Beta)
-0.34
Dividend Yield
N/A
Total Cash/Share
17.68
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for GRCL
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
218 Sangtian Street
Phone
+86 51262626701
Employees
314
Web
https://www.gracellbio.com